CHMP Recommends Three Approvals And Two Label Expansions, Makes One Denial
This article was originally published in The Pink Sheet Daily
Executive Summary
EMEA recommends against use of epoetins in some cancer patients.
You may also be interested in...
UCB’s Vimpat Gets FDA Approval For Epileptic Seizures
Belgian specialty pharma hopes to launch drug in U.S. early next year; says blockbuster sales could follow.
UCB’s Vimpat Gets FDA Approval For Epileptic Seizures
Belgian specialty pharma hopes to launch drug in U.S. early next year; says blockbuster sales could follow.
UCB Takes Back EU Try With Vimpat
Withdrawal follows July “not approvable” letter in diabetic pain.